Servier, founded in 1954, is the first French independent pharmaceutical group. We are present in 140 countries, with more than 21 000 employees, including close to 3000 in R&D.
Sorrento and Servier Enter Into Exclusive Worldwide License and Collaboration Agreement for Development and Commercialization of Anti-PD-1 Antibody
Patients with Advanced Metastatic Colorectal Cancer in Europe Now Have a New Treatment Option as LONSURF® (trifluridine/tipiracil) Receives EU Approval
> All News
© 2016 SERVIER HONG KONG LIMITED, an incorporated company of Servier. All Rights Reserved. Report a side-effect with a drug.